Galleri® Test Adoption Momentum Among Health Systems and Providers

Health systems across the U.S. are redefining cancer screening by offering the Galleri® multi-cancer early detection (MCED) test in addition to guideline recommended cancer screenings. Watch this video to hear about the benefits of MCED testing from physicians leading the charge.
Learn more about Galleri:
grail.com
galleri.com
Rx only. See Important Safety Information: www.galleri.com/
Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.
Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a “Cancer Signal Detected” result. After diagnostic evaluation, around 40% of these people are expected to have a confirmed cancer diagnosis.
Follow us:
/ grail-inc.
/ grailbio
/ grailbio
/ grailbio
www.threads.ne...
/ galleritest
/ galleritest